US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Spdr S&P Biotech Etf

162.50

+0.12000.07%

Pre-market: 161.02-1.4800-0.91%09:10 EDT

Volume:7.36M

Turnover:1.19B

Market Cap:11.52B

PE:8.91

High:163.22

Open:161.00

Low:159.62

Close:162.38

52wk High:169.89

52wk Low:91.10

Shares:70.90M

Float Shares:70.90M

Volume Ratio:0.88

T/O Rate:10.38%

Dividend:0.57

Dividend Rate:0.35%

EPS(TTM):18.23

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP)

HealthCo Healthcare And Wellness REIT (ASX:HCW) Shares Still Lack A Payout Anchor

Simply Wall St.

Movement Alert｜Spdr S&P Biotech Etf Rises 5.02% in Regular Trading, Biotech Sector Rallies on Multi-Factor Tailwinds

Max Healthcare Updates NCLT Proceedings Involving Kalinga Hospital Subsidiary

3 Australian AI Healthcare Stocks Building Real Clinical Imaging Tools

Simply Wall St.

Kelun-Biotech: Buy Rating Reaffirmed as Strong sac-TMT Momentum Drives Target Price Increase from HK$507.11 to HK$642.29

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)

Health Care Roundup: Market Talk

Worldwide Healthcare Trust Boosts Treasury Stock in Share Buyback

US Opening Bell | Stocks open higher; Moderna, Inc. soars 84%; Biotech and chip stocks rally

US Opening Bell

Why Ryman Healthcare (NZSE:RYM) Is Back In The Spotlight

Simply Wall St.

Alkane Resources Stock Leads These Financially Fit Penny Stocks

Simply Wall St.

Ishares Biotech ETF up 3.2%, State Street Spdr S&P Biotech ETF up 2.9%

THOMSON REUTERS

Oncolytics Biotech is Maintained at Buy by HC Wainwright & Co.

Jefferies Adjusts Genscript Biotech's Price Target to HK$30 From HK$15.50, Keeps at Buy

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX) and Irhythm Technologies (IRTC)

Ping An Healthcare And Technology (SEHK:1833) Stock Sinks As Profitability Improves

Simply Wall St.

EPF Boosts Substantial Stake in IHH Healthcare

CH Biotech R&D to Issue NT$700 Million Bonds

MT Newswires Live

Amoytop Biotech Adjusts Fund Allocation After Fundraising Shortfall

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/XBI/news?page=16"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","market":"US","secType":"STK","nameCN":"Spdr S&P Biotech Etf","latestPrice":162.5,"timestamp":1788206400000,"preClose":162.38,"halted":0,"volume":7356083,"hourTrading":{"tag":"盘前","latestPrice":161.02,"preClose":162.5,"latestTime":"09:10 EDT","volume":26624,"amount":4289286.143999999,"timestamp":1788268213893,"change":-1.48,"changeRate":-0.009108,"amplitude":0.012431},"delay":0,"changeRate":0.0007390072669048193,"floatShares":70900000,"shares":70900000,"eps":18.23,"marketStatus":"Pre-Mkt","change":0.12,"latestTime":"09-01 09:10:30 EDT","open":161,"high":163.22,"low":159.6206,"amount":1185944905.9484599,"amplitude":0.022167,"askPrice":161.4,"askSize":300,"bidPrice":161,"bidSize":100,"shortable":3,"etf":1,"ttmEps":18.23,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1788269400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":162.5,"sharesOutstanding":63325000,"nav":162.332292,"aum":11387610309.25,"dividendRate":0.003497,"bidAskSpread":0.000334,"preHourTrading":{"tag":"盘前","latestPrice":161.02,"preClose":162.5,"latestTime":"09:10 EDT","volume":26624,"amount":4289286.143999999,"timestamp":1788268213893,"change":-1.48,"changeRate":-0.009108,"amplitude":0.012431},"postHourTrading":{"tag":"盘后","latestPrice":162.5,"preClose":162.5,"latestTime":"19:50 EDT","volume":82718,"amount":13426735.2877,"timestamp":1788220208580,"change":0,"changeRate":0,"amplitude":0.003746},"volumeRatio":0.8823652678263062,"impliedVol":0.318,"impliedVolPercentile":0.6096},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBI\",,,,,undefined,":{"symbol":"XBI","floatShares":70900000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.8823652678263062,"shares":70900000,"dividePrice":0.5683,"high":163.22,"amplitude":0.022167,"preClose":162.38,"low":159.6206,"week52Low":91.1,"pbRate":"--","week52High":169.89,"institutionHeld":0.8511,"latestPrice":162.5,"committee":-0.5,"eps":18.23,"divideRate":0.003497,"volume":7356083,"delay":0,"ttmEps":18.23,"open":161,"prevYearClose":121.93,"prevWeekClose":162.38,"prevMonthClose":162.5,"prevQuarterClose":158.25,"fiveDayClose":164.17,"twentyDayClose":147.31,"sixtyDayClose":133.42},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBI\",params:#limit:5,,,undefined,":[{"date":"2026-06-22","symbol":"XBI","amount":0.138094,"announcedDate":"2026-06-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-22","defaultRemindTime":1782135000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-24","payableDate":"2026-06-22","currency":"USD","dateTimestamp":1782100800000,"payDate":"2026-06-24"},{"date":"2025-12-22","symbol":"XBI","amount":0.406564,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-24","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-24"},{"date":"2025-09-22","symbol":"XBI","amount":0.02665,"announcedDate":"2025-09-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-22","defaultRemindTime":1758547800000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-24","payableDate":"2025-09-22","currency":"USD","dateTimestamp":1758513600000,"payDate":"2025-09-24"},{"date":"2025-06-23","symbol":"XBI","amount":0.007295,"announcedDate":"2025-06-20","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-23","defaultRemindTime":1750685400000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-25","payableDate":"2025-06-23","currency":"USD","dateTimestamp":1750651200000,"payDate":"2025-06-25"},{"date":"2025-03-24","symbol":"XBI","amount":0.00525,"announcedDate":"2025-03-21","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-24","defaultRemindTime":1742823000000,"name":"SPDR S&P Biotech ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-26","payableDate":"2025-03-24","currency":"USD","dateTimestamp":1742788800000,"payDate":"2025-03-26"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBI\",market:\"US\",,,undefined,":[{"executeDate":"2016-09-16","recordDate":"2016-09-20","paymentDate":"2016-09-26","value":0.031139,"currency":"USD"},{"executeDate":"2016-12-16","recordDate":"2016-12-20","paymentDate":"2016-12-27","value":0.01831,"currency":"USD"},{"executeDate":"2017-03-17","recordDate":"2017-03-21","paymentDate":"2017-03-27","value":0.019702,"currency":"USD"},{"executeDate":"2017-06-16","recordDate":"2017-06-20","paymentDate":"2017-06-26","value":0.110135,"currency":"USD"},{"executeDate":"2017-09-15","recordDate":"2017-09-18","paymentDate":"2017-09-25","value":0.03704,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBI\",pageSize:20,pageCount:16,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660747894","title":"Analysts Offer Insights on Healthcare Companies: Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660747894","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660747894?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:40","pubTimestamp":1787168424,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Annovis Bio (ANVS) and Acurx Pharmaceuticals (ACXP) ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-annovis-bio-anvs-and-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-annovis-bio-anvs-and-acurx-pharmaceuticals-acxp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0029874061.USD","ANVS","BK4563","BK4139","BK4585","LU0128526141.USD","BK4588","BK4581","ACXP","BK4539","HCSG","XLV","XBI","LABU","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660476429","title":"HealthCo Healthcare And Wellness REIT (ASX:HCW) Shares Still Lack A Payout Anchor","url":"https://stock-news.laohu8.com/highlight/detail?id=2660476429","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660476429?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:30","pubTimestamp":1787167831,"startTime":"0","endTime":"0","summary":"HealthCo Healthcare and Wellness REIT came into this result priced for worry, trading at A$0.72 and drifting over the past month even as the long thesis has leaned on hospital-like resilience and infrastructure style income. The headline from these FY26 numbers is not revenue or earnings per share. It is cash flow and distributions.\nFunds from operations, the key measure for real estate investment trusts, was reported at A$0.04 per unit, while underlying look through funds from operations...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9621071-choice2-main-header/1585186711356","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9621071-choice2-main-header/1585186711356"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/real-estate/asx-hcw/healthco-healthcare-and-wellness-reit-shares/news/healthco-healthcare-and-wellness-reit-asxhcw-shares-still-la","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/real-estate/asx-hcw/healthco-healthcare-and-wellness-reit-shares/news/healthco-healthcare-and-wellness-reit-asxhcw-shares-still-la","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK6142","MDIV","BK7149","CFA.SI","SRT.SI","BPRE","8C8U.SI","BK4581","YLDW","BK4585","RNTY","BK4588","CLR.SI","JJJ.SI","RJMG","DFRA","XBI","IQRA","GLS.SI","PSCF","IVRA","SRU.SI","REIT","BK7156","HCW.AU","LABU","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197948700","title":"Movement Alert｜Spdr S&P Biotech Etf Rises 5.02% in Regular Trading, Biotech Sector Rallies on Multi-Factor Tailwinds","url":"https://stock-news.laohu8.com/highlight/detail?id=1197948700","media":"Market Focus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197948700?lang=en_us&edition=fundamental","pubTime":"2026-08-20 03:03","pubTimestamp":1787166194,"startTime":"0","endTime":"0","summary":"On August 19, Spdr S&P Biotech Etf rose 5.02% in regular trading, trading at $168.02/share, with turnover of $1.595 billion.On the news front, the U.S. biotech sector surged broadly as multiple...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660782420","title":"Max Healthcare Updates NCLT Proceedings Involving Kalinga Hospital Subsidiary","url":"https://stock-news.laohu8.com/highlight/detail?id=2660782420","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660782420?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:54","pubTimestamp":1787165698,"startTime":"0","endTime":"0","summary":"Max Healthcare Institute Ltd ( ($IN:MAXHEALTH) ) has provided an announcement. Max Healthcare Institute Ltd is a major private hospital operator in...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/max-healthcare-updates-nclt-proceedings-involving-kalinga-hospital-subsidiary?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/max-healthcare-updates-nclt-proceedings-involving-kalinga-hospital-subsidiary?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4585","HCSG","LU0029874061.USD","XBI","LU0128526141.USD","BK4588","BK4137","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660764594","title":"3 Australian AI Healthcare Stocks Building Real Clinical Imaging Tools","url":"https://stock-news.laohu8.com/highlight/detail?id=2660764594","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660764594?lang=en_us&edition=fundamental","pubTime":"2026-08-20 02:36","pubTimestamp":1787164616,"startTime":"0","endTime":"0","summary":"US 10 year Treasury yields are sitting near multi month highs as investors reassess inflation risks and government borrowing needs. Higher long term rates can pressure broad equity valuations but also push more capital toward companies that aim to cut costs and improve productivity. AI healthcare stocks fit that story. This article walks through three Transformative AI Healthcare Stocks from our screener to help you spot potential long term winners.\nThe stocks covered in the list below are...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/healthcare/asx-ime/imexhs-shares/news/3-australian-ai-healthcare-stocks-building-real-clinical-ima","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/healthcare/asx-ime/imexhs-shares/news/3-australian-ai-healthcare-stocks-building-real-clinical-ima","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4137","STW.AU","ARTY","ZYAU.AU","SHG.AU","BEAR.AU","OZR.AU","DACE.AU","AYA.AU","EIGA.AU","IIGF.AU","GEAR.AU","VAP.AU","AIPO","IISV.AU","GIVE.AU","LABU","LU0029874061.USD","IME.AU","LU0128526141.USD","QFN.AU","BBOZ.AU","VAS.AU","VGT","BK4581","AGIX","QRE.AU","XBI","XAO.AU","BK4585","XKO.AU","BK7094","TCAF","XJO.AU","IOZ.AU","IMLC.AU","CHAT","E200.AU","CGCV","QTOC","BK4588","VTHR","HCSG","XLV","SLF.AU","OZF.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660427542","title":"Kelun-Biotech: Buy Rating Reaffirmed as Strong sac-TMT Momentum Drives Target Price Increase from HK$507.11 to HK$642.29","url":"https://stock-news.laohu8.com/highlight/detail?id=2660427542","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660427542?lang=en_us&edition=fundamental","pubTime":"2026-08-20 01:25","pubTimestamp":1787160341,"startTime":"0","endTime":"0","summary":"CMB International Securities analyst Jill Wu maintained a Buy rating on Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Class H today and set a p...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/kelun-biotech-buy-rating-reaffirmed-as-strong-sac-tmt-momentum-drives-target-price-increase-from-hk507-11-to-hk642-29-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/kelun-biotech-buy-rating-reaffirmed-as-strong-sac-tmt-momentum-drives-target-price-increase-from-hk507-11-to-hk642-29-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660542263","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660542263","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660542263?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:30","pubTimestamp":1787157016,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Sil...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-atai-beckley-n-v-atai-inspiremd-nspr-and-silexion-therapeutics-slxn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-atai-beckley-n-v-atai-inspiremd-nspr-and-silexion-therapeutics-slxn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4581","XLV","BK4198","BK4539","BK4585","HCSG","BK4007","SLXN","BK4588","LU0029874061.USD","NSPR","XBI","LU0128526141.USD","BK4139","BK4137","ATAI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660228194","title":"Health Care Roundup: Market Talk","url":"https://stock-news.laohu8.com/highlight/detail?id=2660228194","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660228194?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:20","pubTimestamp":1787156400,"startTime":"0","endTime":"0","summary":"The latest Market Talks covering the Health Care sector. Published exclusively on Dow Jones Newswires at 4:20 ET, 12:20 ET and 16:50 ET.1055 ET - The experimental mRNA-based vaccine from Moderna and M","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XLV","BK4588","XBI","BK4581","LABU","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660424236","title":"Worldwide Healthcare Trust Boosts Treasury Stock in Share Buyback","url":"https://stock-news.laohu8.com/highlight/detail?id=2660424236","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660424236?lang=en_us&edition=fundamental","pubTime":"2026-08-20 00:02","pubTimestamp":1787155357,"startTime":"0","endTime":"0","summary":"Worldwide Healthcare Trust PLC GBP ( ($GB:WWH) ) just unveiled an update. Worldwide Healthcare Trust PLC has executed a market purchase of 1,052,58...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-in-share-buyback?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/worldwide-healthcare-trust-boosts-treasury-stock-in-share-buyback?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","XBI","HCSG","BK4585","XLV","LABU","BK4581","BK4137","LU0029874061.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146270236","title":"US Opening Bell | Stocks open higher; Moderna, Inc. soars 84%; Biotech and chip stocks rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1146270236","media":"US Opening Bell","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146270236?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:32","pubTimestamp":1787146322,"startTime":"0","endTime":"0","summary":"MarketAugust 19, U.S. stocks opened broadly higher as investors welcomed benign Fed minutes and upbeat earnings. The Dow Jones rose about 180 points or 0.3%, the S&P 500 added 0.4%, and the...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"dad8a4695a004b8f99e17c4a581195e8","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4503","SEMY","SOXL","INTW","BK4535","IE00B5MMRT66.SGD","LU0348825331.USD","SOXM","BK4581","SMH","SSG","USD","BK4526","FTXL","XBI","TSXU","SOXQ","BK4558","BK4534","SMHX","IE00B543WZ88.USD","SMHU","BK4533","TEKX","SOXY","BK4548","BK4588","BK4568","LU0417516902.SGD","GNOM","WDNA","BK4501","CHPS","ZTO","BK4551","IE00BPRC5H50.USD","BK4139","BK4505","SOXX","BK4532","PSI","SOXS","BK4585","CHPY","BK4131","IDNA","BK4502","MRNY","LGHT","SOXW","XSD","MRNA","MRNX","LINT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660424022","title":"Why Ryman Healthcare (NZSE:RYM) Is Back In The Spotlight","url":"https://stock-news.laohu8.com/highlight/detail?id=2660424022","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660424022?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:31","pubTimestamp":1787146306,"startTime":"0","endTime":"0","summary":"Ryman Healthcare (NZSE:RYM) is back in focus after director James Miller signalled his intention to step down to prioritise his new role as Chair of the Financial Markets Authority.\nSee our latest analysis for Ryman Healthcare.\nThe recent reshuffle on Ryman Healthcare’s board comes at a time when the share price is around NZ$2.10, with short term share price returns mixed and longer term total shareholder returns still showing a pronounced decline over three and five years. This pattern...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6033000-choice2-main-header/1585186569462"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/why-ryman-healthcare-nzserym-is-back-in-the-spotlight","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/nz/healthcare/nzx-rym/ryman-healthcare-shares/news/why-ryman-healthcare-nzserym-is-back-in-the-spotlight","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["RYM.NZ","BK4585","RYM","BK4588","BK8050","BK4152","BK4581","XLV","XBI","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660429545","title":"Alkane Resources Stock Leads These Financially Fit Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660429545","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660429545?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:30","pubTimestamp":1787146240,"startTime":"0","endTime":"0","summary":"US housing data now shows a clear strain from tighter mortgage finance. That pressure can keep many buyers on the sidelines and may push more attention toward the stock market, including Financially Fit Penny Stocks. These are lower priced companies filtered for healthier balance sheets. This article examines three stocks from the screener that some investors use to stay engaged in equities without stretching their budgets.\nThe stocks highlighted below are just a small sample from this...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2053000-choice2-main-header/1585186554136"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-leads-these-financially-fit-penny-sto","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-alk/alkane-resources-shares/news/alkane-resources-stock-leads-these-financially-fit-penny-sto","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["XME","BK4535","BK7067","BK4581","BK7501","ALK.AU","XBI","BK7508","SPHQ","XLV","BK7103","BK7104","SIG.AU","MSB.AU","LABU","BK7506","BK4585","UYM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660425673","title":"Ishares Biotech ETF up 3.2%, State Street Spdr S&P Biotech ETF up 2.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660425673","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660425673?lang=en_us&edition=fundamental","pubTime":"2026-08-19 21:11","pubTimestamp":1787145068,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260819:nL4N44G13N:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4581","BK4585","XBI","BK4588","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660423442","title":"Oncolytics Biotech is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2660423442","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660423442?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:48","pubTimestamp":1787143680,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ONCY/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660284624","title":"Jefferies Adjusts Genscript Biotech's Price Target to HK$30 From HK$15.50, Keeps at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2660284624","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660284624?lang=en_us&edition=fundamental","pubTime":"2026-08-19 20:14","pubTimestamp":1787141669,"startTime":"0","endTime":"0","summary":"Genscript Biotech (HKG:1548) has an average rating of buy and mean price target of HK$30.42, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660440196","title":"Analysts Offer Insights on Healthcare Companies: Quest Diagnostics (DGX) and Irhythm Technologies (IRTC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2660440196","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660440196?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:40","pubTimestamp":1787139607,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Quest Diagnostics (DGX) and Irhythm Technologies (IR...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-and-irhythm-technologies-irtc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-quest-diagnostics-dgx-and-irhythm-technologies-irtc-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2506951958.HKD","XLV","BK4585","BK4137","LABU","LU0950375773.USD","BK4567","LU1854104046.USD","HCSG","LU0029874061.USD","BK4196","DGX","BK4563","LU2506952097.USD","LU1854103824.USD","BK4581","LU0128526141.USD","LU0823417737.USD","LU2506952170.USD","IRTC","XBI","BK4082","LU0823417653.USD","LU2506951875.HKD","BK4588","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660440258","title":"Ping An Healthcare And Technology (SEHK:1833) Stock Sinks As Profitability Improves","url":"https://stock-news.laohu8.com/highlight/detail?id=2660440258","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660440258?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:26","pubTimestamp":1787138777,"startTime":"0","endTime":"0","summary":"Ping An Healthcare and Technology has been treated like a high growth digital health platform with a valuation to match, yet the stock closed at HK$7.13 on 19 August, with the past three months delivering a decline of about 23%. Against that weaker share price, the H1 2026 headline is simple: the company stayed solidly profitable with basic earnings per share of ¥0.10 and net income of ¥219.3 million, while trailing net profit margin held at 8.5%. The market reaction and the income statement...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/ping-an-healthcare-and-technology-sehk1833-stock-sinks-as-pr","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/consumer-retailing/hkg-1833/ping-an-healthcare-and-technology-shares/news/ping-an-healthcare-and-technology-sehk1833-stock-sinks-as-pr","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["HCSG","BK1515","BK1219","BK1142","BK4588","XLV","01833","BK1247","BK1571","BK4581","XBI","LABU","BK1617","BK4585","LU0029874061.USD","BK1615","LU0128526141.USD","BK4137"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660447396","title":"EPF Boosts Substantial Stake in IHH Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2660447396","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660447396?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:52","pubTimestamp":1787136723,"startTime":"0","endTime":"0","summary":"IHH Healthcare Bhd ( ($IHHHF) ) has shared an update. Malaysia’s Employees Provident Fund Board has increased its stake in IHH Healthcare Berhad th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/epf-boosts-substantial-stake-in-ihh-healthcare?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/epf-boosts-substantial-stake-in-ihh-healthcare?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","XLV","XBI","BK4585","LU0029874061.USD","BK4581","BK4137","LU0128526141.USD","HCSG","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660444466","title":"CH Biotech R&D to Issue NT$700 Million Bonds","url":"https://stock-news.laohu8.com/highlight/detail?id=2660444466","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660444466?lang=en_us&edition=fundamental","pubTime":"2026-08-19 18:23","pubTimestamp":1787134987,"startTime":"0","endTime":"0","summary":"CH Biotech R&D  board approved plans to issue NT$700 million of its first domestic secured convertible bonds, according to a Wednesday Taiwan Stock Exchange filing.The three-year bonds will have a face value of NT$100,000 each and a zero coupon rate. The tentative issue price is set at 100% to 101% of face value.The bonds will be secured by a bank guarantee and offered publicly through a book-building process.CH Biotech said proceeds will be used to repay bank loans and strengthen working capital.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","BK4581","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660441539","title":"Amoytop Biotech Adjusts Fund Allocation After Fundraising Shortfall","url":"https://stock-news.laohu8.com/highlight/detail?id=2660441539","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660441539?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:50","pubTimestamp":1787133051,"startTime":"0","endTime":"0","summary":"Xiamen Amoytop Biotech  adjusted the proposed investment amounts for its convertible bond fundraising projects, following a net proceeds shortfall.Net proceeds came to 1.52 billion yuan, lower than the planned 1.53 billion yuan, according to a Wednesday filing with the Shanghai bourse.The adjustments affect the Biotech innovation integration center project, which saw its allocation reduced to 446.2 million yuan from 461.9 million yuan.Shares of the drugmaker were up 7% Wednesday.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","688278","BK0239","XBI","BK4581","FCA"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":18,"pageCount":16,"totalSize":343,"code":"91000000","status":"200"}]}}